Genetic abnormalities in 30 people in a Dutch fishing village and about a hundred South African Afrikaners have provided the clues needed to develop sclerostin inhibitors as a potential new treatment for osteoporosis. Professor Socrates Papapoulos, from the Leiden University Medical Center in The Netherlands, described the progressive bone overgrowth that occurred during the first ...
Sclerostin inhibition promising in osteoporosis
By Tony James
4 Nov 2015